Stockley R A, Finnegan P, Bishop J M
Thorax. 1977 Oct;32(5):601-5. doi: 10.1136/thx.32.5.601.
Terbutaline sulphate was given intravenously to 10 patients with pulmonary vascular disease secondary to chronic hypoxia. The resting cardiac index increased after terbutaline in all the patients between 5 and 74% above the control level. The greatest change was seen in patients who had received the largest total dose. The rise in cardiac index was associated with a fall in pulmonary vascular resistance although mean pulmonary artery pressure remained unaltered. There was a significant increase in the venous admixture but this did not adversely affect the arterial oxygen tension. The peak expiratory flow rate did not change significantly but there was an increase in ventilation from a mean value of 4.36 1/min/m2 to 4.67 1/min/m2. The results show that terbutaline has little adverse effect on the pulmonary circulation or gas exchange in patients with irreversible airways disease who are in a stable state.
对10例继发于慢性缺氧的肺血管疾病患者静脉注射硫酸特布他林。所有患者在注射特布他林后静息心指数均升高,比对照水平高出5%至74%。接受总剂量最大的患者变化最大。心指数升高与肺血管阻力下降相关,尽管平均肺动脉压保持不变。静脉混合血有显著增加,但这并未对动脉血氧张力产生不利影响。呼气峰值流速无显著变化,但通气量从平均值4.36升/分钟/平方米增加到4.67升/分钟/平方米。结果表明,特布他林对处于稳定状态的不可逆气道疾病患者的肺循环或气体交换几乎没有不良影响。